Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,119 | 410 | 88.4% |
| Travel and Lodging | $1,056 | 3 | 8.4% |
| Education | $406.93 | 15 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Baxter Healthcare | $2,217 | 22 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,832 | 65 | $0 (2024) |
| Amgen Inc. | $1,300 | 45 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $895.08 | 18 | $0 (2023) |
| Daiichi Sankyo Inc. | $751.14 | 29 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $548.71 | 29 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $533.27 | 28 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $451.04 | 17 | $0 (2024) |
| Vifor Pharma, Inc. | $301.61 | 17 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $299.61 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,346 | 56 | Amgen Inc. ($229.95) |
| 2023 | $1,778 | 56 | Baxter Healthcare ($287.75) |
| 2022 | $1,901 | 63 | Amgen Inc. ($428.66) |
| 2021 | $3,024 | 112 | AstraZeneca Pharmaceuticals LP ($514.17) |
| 2020 | $1,347 | 56 | AstraZeneca Pharmaceuticals LP ($447.48) |
| 2019 | $2,690 | 59 | BAXTER HEALTHCARE ($1,498) |
| 2018 | $311.80 | 15 | Medtronic Vascular, Inc. ($53.87) |
| 2017 | $185.24 | 11 | Relypsa, Inc. ($70.68) |
All Payment Transactions
428 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: NEPHROLOGY | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/01/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: NEPHROLOGY | ||||||
| 10/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Catheter Lock Solution | ||||||
| 10/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Obesity | ||||||
| 10/04/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: NEPHROLOGY | ||||||
| 09/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: Cardio-renal | ||||||
| 09/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Nephrology | ||||||
| 09/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: Immunology | ||||||
| 09/04/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Catheter Lock Solution | ||||||
| 08/26/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,571 | 3,036 | $698,556 | $250,953 |
| 2022 | 20 | 1,286 | 2,389 | $532,112 | $185,469 |
| 2021 | 24 | 1,404 | 2,751 | $635,318 | $227,783 |
| 2020 | 20 | 1,503 | 2,847 | $664,812 | $230,296 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 247 | 622 | $129,998 | $53,570 | 41.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 228 | 579 | $133,749 | $52,693 | 39.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 276 | 817 | $131,537 | $48,671 | 37.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 234 | 250 | $112,250 | $32,662 | 29.1% |
| 36558 | Insertion of tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 49 | 51 | $31,824 | $9,946 | 31.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 11 | 36 | $21,024 | $7,916 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $17,435 | $6,592 | 37.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 54 | 108 | $16,200 | $5,951 | 36.7% |
| 36906 | Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment and placement of stent with review by radiologist | Facility | 2023 | 15 | 16 | $18,400 | $5,623 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 37 | $10,397 | $4,772 | 45.9% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Facility | 2023 | 22 | 23 | $12,374 | $4,174 | 33.7% |
| 36589 | Removal of tunneled central venous tube | Facility | 2023 | 33 | 36 | $14,364 | $3,477 | 24.2% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Facility | 2023 | 23 | 28 | $10,528 | $3,171 | 30.1% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 41 | 45 | $8,505 | $2,616 | 30.8% |
| 36581 | Replacement of tunneled central venous tube | Facility | 2023 | 17 | 20 | $8,420 | $2,467 | 29.3% |
| 36907 | Balloon dilation of dialysis segment with review by radiologist | Facility | 2023 | 12 | 15 | $4,935 | $1,663 | 33.7% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 16 | 21 | $4,431 | $1,241 | 28.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 75 | 106 | $2,862 | $987.77 | 34.5% |
| 77001 | Fluoroscopic guidance for insertion or removal of central vein access device | Facility | 2023 | 61 | 72 | $3,747 | $983.35 | 26.2% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 59 | 70 | $2,600 | $767.20 | 29.5% |
| 75820 | Review by radiologist of 1 arm or leg vein of 1 arm or leg image | Facility | 2023 | 12 | 14 | $1,176 | $535.22 | 45.5% |
| 36005 | Injection for x-ray imaging procedure into vein of arm or leg | Facility | 2023 | 13 | 15 | $1,800 | $474.54 | 26.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 241 | 660 | $152,460 | $51,906 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 192 | 476 | $99,484 | $41,442 | 41.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 235 | 540 | $86,940 | $29,302 | 33.7% |
About Dr. Diptesh Gupta, M.D
Dr. Diptesh Gupta, M.D is a Nephrology healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1326201260.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Diptesh Gupta, M.D has received a total of $12,582 in payments from pharmaceutical and medical device companies, with $1,346 received in 2024. These payments were reported across 428 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($11,119).
As a Medicare-enrolled provider, Gupta has provided services to 5,764 Medicare beneficiaries, totaling 11,023 services with total Medicare billing of $894,501. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Tulsa, OK
- Active Since 07/09/2008
- Last Updated 02/24/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1326201260
Products in Payments
- Non-Franchise (NOF) - NonProduct (Biological) $1,391
- LOKELMA (Drug) $1,173
- Parsabiv (Drug) $776.95
- INJECTAFER (Drug) $751.14
- Veltassa (Drug) $564.18
- FARXIGA (Drug) $494.03
- JYNARQUE (Drug) $468.56
- LUPKYNIS (Drug) $451.04
- RAYALDEE (Drug) $388.68
- Renal - PD (Device) $310.77
- Kerendia (Drug) $299.61
- RUBY Coil (Device) $274.87
- KRYSTEXXA (Biological) $229.59
- TAVNEOS (Drug) $198.55
- Tavneos (Drug) $192.75
- Rituxan (Biological) $165.70
- BENLYSTA (Biological) $161.93
- Monoferric (Drug) $145.06
- Rayaldee (Drug) $144.59
- Renal - PrisMax System (Device) $136.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Tulsa
Dr. Sunil Agrawal, Md, MD
Nephrology — Payments: $49,258
Pranay Kathuria, Md Facp, MD FACP
Nephrology — Payments: $18,785
Kevin Fu, Md, MD
Nephrology — Payments: $12,272
Ms. Janet Russell, Md, MD
Nephrology — Payments: $12,209
Bobby Muthalaly, Md, MD
Nephrology — Payments: $11,730
Dr. Narottam Regmi, Md, MD
Nephrology — Payments: $10,684